Pilot Study of Safety and Efficacy of Spheramine

NCT00761436 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Study was completed, only life long extended follow-up phase was discontinued after 12 years

Conditions

Parkinson''s Disease

Interventions

BIOLOGICAL: Spheramine (BAY86-5280)

Sponsor

Bayer

Collaborators

[object Object]